Notable Drug Stock Losers (PFE, JNJ, MRK, TEVA, BSX)

Pfizer Inc. (NYSE:PFE) slid 2.02% to $15.50. Earlier this week, Dow Jones reported that Pfizer is likely to buy a controlling stake in India's Piramal Healthcare Ltd. in a $1.50 billion-$1.80 billion deal. Talks between the two companies are in the final stages, adding that Pfizer is likely to pay INR725 a share for the stake.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Johnson & Johnson (NYSE:JNJ) lost 1.64% to $61.20 on 3.23 million shares. 

Merck & Co., Inc. (NYSE:MRK) declines 0.98% to $32.30 on 4.77 million shares.

Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) falls 0.20% to $55.27. Teva said Tuesday that it entered an agreement covering its generic version of AstraZeneca's Entocort treatment for Crohn's disease. Under a license from AstraZeneca, Teva will be able to enter the U.S. market with its generic version on Feb. 15, 2012, or earlier under certain circumstances.

Boston Scientific Corporation (NYSE:BSX) decreases 3.73% to $6.45.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.